Delays in idiopathic pulmonary fibrosis diagnosis and treatment: Time for change
Open Access
- 30 November 2021
- journal article
- editorial
- Published by Wiley in Respirology
- Vol. 27 (1) , 10-11
Abstract
See related articleKeywords
This publication has 11 references indexed in Scilit:
- Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and MortalityAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY surveyBMC Pulmonary Medicine, 2018
- Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countriesBMC Pulmonary Medicine, 2017
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2014
- Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001